Medical Care

Global Inflammatory Bowel Disease Therapy Market Insights, Forecast to 2030

Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.
Market Analysis and Insights: Global Inflammatory Bowel Disease Therapy Market
The global Inflammatory Bowel Disease Therapy market is projected to grow from US$ 17970 million in 2024 to US$ 22210 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period.
The US & Canada market for Inflammatory Bowel Disease Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Inflammatory Bowel Disease Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Inflammatory Bowel Disease Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Inflammatory Bowel Disease Therapy include Johnson & Johnson, AbbVie, Takeda Pharmaceutical Company, Abbott, Celgene Corporation, Innovate Biopharma, Cosmo Pharmaceuticals, Gilead Sciences and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Inflammatory Bowel Disease Therapy is widely used in various fields, such as Hospital, Medical Research Organization and Other,, etc. Hospital provides greatest supports to the Inflammatory Bowel Disease Therapy industry development. In 2023, global % revenue of Inflammatory Bowel Disease Therapy went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Inflammatory Bowel Disease Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Inflammatory Bowel Disease Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Inflammatory Bowel Disease Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Inflammatory Bowel Disease Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Inflammatory Bowel Disease Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Inflammatory Bowel Disease Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Johnson & Johnson
AbbVie
Takeda Pharmaceutical Company
Abbott
Celgene Corporation
Innovate Biopharma
Cosmo Pharmaceuticals
Gilead Sciences
Pfizer
Segment by Type
Ulcerative Colitis
Crohns Disease
Others
Segment by Application
Hospital
Medical Research Organization
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Inflammatory Bowel Disease Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inflammatory Bowel Disease Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inflammatory Bowel Disease Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Ulcerative Colitis
1.2.3 Crohns Disease
1.2.4 Others
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Research Organization
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease Therapy Market Perspective (2019-2030)
2.2 Global Inflammatory Bowel Disease Therapy Growth Trends by Region
2.2.1 Inflammatory Bowel Disease Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Inflammatory Bowel Disease Therapy Historic Market Size by Region (2019-2024)
2.2.3 Inflammatory Bowel Disease Therapy Forecasted Market Size by Region (2025-2030)
2.3 Inflammatory Bowel Disease Therapy Market Dynamics
2.3.1 Inflammatory Bowel Disease Therapy Industry Trends
2.3.2 Inflammatory Bowel Disease Therapy Market Drivers
2.3.3 Inflammatory Bowel Disease Therapy Market Challenges
2.3.4 Inflammatory Bowel Disease Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Inflammatory Bowel Disease Therapy by Players
3.1.1 Global Inflammatory Bowel Disease Therapy Revenue by Players (2019-2024)
3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Inflammatory Bowel Disease Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Inflammatory Bowel Disease Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapy Revenue in 2023
3.5 Global Key Players of Inflammatory Bowel Disease Therapy Head office and Area Served
3.6 Global Key Players of Inflammatory Bowel Disease Therapy, Product and Application
3.7 Global Key Players of Inflammatory Bowel Disease Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease Therapy Breakdown Data by Type
4.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Type (2019-2024)
4.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2025-2030)
5 Inflammatory Bowel Disease Therapy Breakdown Data by Application
5.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Application (2019-2024)
5.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Inflammatory Bowel Disease Therapy Market Size (2019-2030)
6.2 North America Inflammatory Bowel Disease Therapy Market Size by Type
6.2.1 North America Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024)
6.2.2 North America Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030)
6.2.3 North America Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
6.3 North America Inflammatory Bowel Disease Therapy Market Size by Application
6.3.1 North America Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024)
6.3.2 North America Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030)
6.3.3 North America Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
6.4 North America Inflammatory Bowel Disease Therapy Market Size by Country
6.4.1 North America Inflammatory Bowel Disease Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024)
6.4.3 North America Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease Therapy Market Size (2019-2030)
7.2 Europe Inflammatory Bowel Disease Therapy Market Size by Type
7.2.1 Europe Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024)
7.2.2 Europe Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030)
7.2.3 Europe Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
7.3 Europe Inflammatory Bowel Disease Therapy Market Size by Application
7.3.1 Europe Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024)
7.3.2 Europe Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030)
7.3.3 Europe Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
7.4 Europe Inflammatory Bowel Disease Therapy Market Size by Country
7.4.1 Europe Inflammatory Bowel Disease Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024)
7.4.3 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Inflammatory Bowel Disease Therapy Market Size (2019-2030)
8.2 China Inflammatory Bowel Disease Therapy Market Size by Type
8.2.1 China Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024)
8.2.2 China Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030)
8.2.3 China Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
8.3 China Inflammatory Bowel Disease Therapy Market Size by Application
8.3.1 China Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024)
8.3.2 China Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030)
8.3.3 China Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Inflammatory Bowel Disease Therapy Market Size (2019-2030)
9.2 Asia Inflammatory Bowel Disease Therapy Market Size by Type
9.2.1 Asia Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024)
9.2.2 Asia Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030)
9.2.3 Asia Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
9.3 Asia Inflammatory Bowel Disease Therapy Market Size by Application
9.3.1 Asia Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024)
9.3.2 Asia Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030)
9.3.3 Asia Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
9.4 Asia Inflammatory Bowel Disease Therapy Market Size by Region
9.4.1 Asia Inflammatory Bowel Disease Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Inflammatory Bowel Disease Therapy Market Size by Region (2019-2024)
9.4.3 Asia Inflammatory Bowel Disease Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Introduction
11.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.1.5 Johnson & Johnson Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Inflammatory Bowel Disease Therapy Introduction
11.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.2.5 AbbVie Recent Developments
11.3 Takeda Pharmaceutical Company
11.3.1 Takeda Pharmaceutical Company Company Details
11.3.2 Takeda Pharmaceutical Company Business Overview
11.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Introduction
11.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.3.5 Takeda Pharmaceutical Company Recent Developments
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Inflammatory Bowel Disease Therapy Introduction
11.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.4.5 Abbott Recent Developments
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Introduction
11.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.5.5 Celgene Corporation Recent Developments
11.6 Innovate Biopharma
11.6.1 Innovate Biopharma Company Details
11.6.2 Innovate Biopharma Business Overview
11.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Introduction
11.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.6.5 Innovate Biopharma Recent Developments
11.7 Cosmo Pharmaceuticals
11.7.1 Cosmo Pharmaceuticals Company Details
11.7.2 Cosmo Pharmaceuticals Business Overview
11.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Introduction
11.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.7.5 Cosmo Pharmaceuticals Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Introduction
11.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.8.5 Gilead Sciences Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Inflammatory Bowel Disease Therapy Introduction
11.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.9.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Ulcerative Colitis
Table 3. Key Players of Crohns Disease
Table 4. Key Players of Others
Table 5. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Inflammatory Bowel Disease Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Inflammatory Bowel Disease Therapy Market Share by Region (2019-2024)
Table 9. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Inflammatory Bowel Disease Therapy Market Share by Region (2025-2030)
Table 11. Inflammatory Bowel Disease Therapy Market Trends
Table 12. Inflammatory Bowel Disease Therapy Market Drivers
Table 13. Inflammatory Bowel Disease Therapy Market Challenges
Table 14. Inflammatory Bowel Disease Therapy Market Restraints
Table 15. Global Inflammatory Bowel Disease Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Inflammatory Bowel Disease Therapy Revenue Share by Players (2019-2024)
Table 17. Global Top Inflammatory Bowel Disease Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2023)
Table 18. Global Inflammatory Bowel Disease Therapy Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Inflammatory Bowel Disease Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Inflammatory Bowel Disease Therapy, Headquarters and Area Served
Table 21. Global Key Players of Inflammatory Bowel Disease Therapy, Product and Application
Table 22. Global Key Players of Inflammatory Bowel Disease Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2019-2024)
Table 26. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2025-2030)
Table 28. Global Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Inflammatory Bowel Disease Therapy Revenue Share by Application (2019-2024)
Table 30. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Inflammatory Bowel Disease Therapy Revenue Share by Application (2025-2030)
Table 32. North America Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Inflammatory Bowel Disease Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Inflammatory Bowel Disease Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Inflammatory Bowel Disease Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Inflammatory Bowel Disease Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Inflammatory Bowel Disease Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Inflammatory Bowel Disease Therapy Product
Table 67. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024) & (US$ Million)
Table 68. Johnson & Johnson Recent Developments
Table 69. AbbVie Company Details
Table 70. AbbVie Business Overview
Table 71. AbbVie Inflammatory Bowel Disease Therapy Product
Table 72. AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024) & (US$ Million)
Table 73. AbbVie Recent Developments
Table 74. Takeda Pharmaceutical Company Company Details
Table 75. Takeda Pharmaceutical Company Business Overview
Table 76. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Product
Table 77. Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024) & (US$ Million)
Table 78. Takeda Pharmaceutical Company Recent Developments
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Inflammatory Bowel Disease Therapy Product
Table 82. Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024) & (US$ Million)
Table 83. Abbott Recent Developments
Table 84. Celgene Corporation Company Details
Table 85. Celgene Corporation Business Overview
Table 86. Celgene Corporation Inflammatory Bowel Disease Therapy Product
Table 87. Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024) & (US$ Million)
Table 88. Celgene Corporation Recent Developments
Table 89. Innovate Biopharma Company Details
Table 90. Innovate Biopharma Business Overview
Table 91. Innovate Biopharma Inflammatory Bowel Disease Therapy Product
Table 92. Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024) & (US$ Million)
Table 93. Innovate Biopharma Recent Developments
Table 94. Cosmo Pharmaceuticals Company Details
Table 95. Cosmo Pharmaceuticals Business Overview
Table 96. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Product
Table 97. Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024) & (US$ Million)
Table 98. Cosmo Pharmaceuticals Recent Developments
Table 99. Gilead Sciences Company Details
Table 100. Gilead Sciences Business Overview
Table 101. Gilead Sciences Inflammatory Bowel Disease Therapy Product
Table 102. Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024) & (US$ Million)
Table 103. Gilead Sciences Recent Developments
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Inflammatory Bowel Disease Therapy Product
Table 107. Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024) & (US$ Million)
Table 108. Pfizer Recent Developments
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Inflammatory Bowel Disease Therapy Market Share by Type: 2023 VS 2030
Figure 3. Ulcerative Colitis Features
Figure 4. Crohns Disease Features
Figure 5. Others Features
Figure 6. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Inflammatory Bowel Disease Therapy Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Medical Research Organization Case Studies
Figure 10. Other Case Studies
Figure 11. Inflammatory Bowel Disease Therapy Report Years Considered
Figure 12. Global Inflammatory Bowel Disease Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Inflammatory Bowel Disease Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Inflammatory Bowel Disease Therapy Market Share by Region: 2023 VS 2030
Figure 15. Global Inflammatory Bowel Disease Therapy Market Share by Players in 2023
Figure 16. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapy Revenue in 2023
Figure 18. North America Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
Figure 20. North America Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
Figure 21. North America Inflammatory Bowel Disease Therapy Market Share by Country (2019-2030)
Figure 22. United States Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Inflammatory Bowel Disease Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
Figure 26. Europe Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
Figure 27. Europe Inflammatory Bowel Disease Therapy Market Share by Country (2019-2030)
Figure 28. Germany Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Inflammatory Bowel Disease Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
Figure 36. China Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
Figure 37. Asia Inflammatory Bowel Disease Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
Figure 39. Asia Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
Figure 40. Asia Inflammatory Bowel Disease Therapy Market Share by Region (2019-2030)
Figure 41. Japan Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Inflammatory Bowel Disease Therapy Market Share by Country (2019-2030)
Figure 51. Brazil Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Inflammatory Bowel Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2019-2024)
Figure 58. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2019-2024)
Figure 59. Takeda Pharmaceutical Company Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2019-2024)
Figure 60. Abbott Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2019-2024)
Figure 61. Celgene Corporation Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2019-2024)
Figure 62. Innovate Biopharma Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2019-2024)
Figure 63. Cosmo Pharmaceuticals Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2019-2024)
Figure 64. Gilead Sciences Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2019-2024)
Figure 65. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies